Is clinical disease activity index (CDAI) a reliable parameter in the assessment of rheumatoid arthritis patients treated with TNF antagonists?

被引：0
|
作者：
Inanc, N. [1 ]
Direskeneli, H. [1 ]
机构：
[1] Marmara Med Sch, Div Rheumatol, Istanbul, Turkey
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2007年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：173 / 173
页数：1
相关论文
共 50 条
  • [31] Patients' and clinicians' perspectives on the clinical utility of the Rheumatoid Arthritis Foot Disease Activity Index
    Hoque, A.
    Hendry, G. J.
    Steultjens, M. P.
    Dickson, D. M.
    SCOTTISH MEDICAL JOURNAL, 2022, 67 (01) : 48 - 48
  • [32] PATIENTS' AND CLINICIANS' PERSPECTIVES ON THE CLINICAL UTILITY OF THE RHEUMATOID ARTHRITIS FOOT DISEASE ACTIVITY INDEX
    Hoque, Anika
    RHEUMATOLOGY, 2022, 61 : I106 - I106
  • [33] Patients’ and clinicians’ perspectives on the clinical utility of the Rheumatoid Arthritis Foot Disease Activity Index
    Anika Hoque
    Martijn Steultjens
    Diane M. Dickson
    Gordon J. Hendry
    Rheumatology International, 2022, 42 : 1807 - 1817
  • [34] Evaluation of disease activity in rheumatoid arthritis by Routine Assessment of Patient Index Data 3 (RAPID3) and its correlation to Disease Activity Score 28 (DAS28) and Clinical Disease Activity Index (CDAI): an Indian experience
    Singh, H.
    Gupta, V.
    Ray, S.
    Kumar, H.
    Talapatra, P.
    Kaur, M.
    Kumar, S.
    Arya, S.
    Mathur, R.
    Ghangas, N.
    CLINICAL RHEUMATOLOGY, 2012, 31 (12) : 1663 - 1669
  • [35] Patients' and clinicians' perspectives on the clinical utility of the Rheumatoid Arthritis Foot Disease Activity Index
    Hoque, Anika
    Steultjens, Martijn
    Dickson, Diane M.
    Hendry, Gordon J.
    RHEUMATOLOGY INTERNATIONAL, 2022, 42 (10) : 1807 - 1817
  • [36] PHYSICIAN'S GLOBAL ASSESSMENT OF DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS IS A RELIABLE AND RESPONSIVE TOOL IN CLINICAL PRACTICE
    Saraiva, L.
    Brites, L.
    Cunha, A. R.
    Assuncao, H.
    Prata, A. R.
    Luis, M.
    Costa, F.
    Freitas, P.
    Sousa, M.
    Da Silva, J. A. P.
    Duarte, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1407 - 1408
  • [37] Evaluation of disease activity in rheumatoid arthritis by Routine Assessment of Patient Index Data 3 (RAPID3) and its correlation to Disease Activity Score 28 (DAS28) and Clinical Disease Activity Index (CDAI): an Indian experience
    H. Singh
    V. Gupta
    S. Ray
    H. Kumar
    P. Talapatra
    M. Kaur
    S. Kumar
    S. Arya
    R. Mathur
    N. Ghangas
    Clinical Rheumatology, 2012, 31 : 1663 - 1669
  • [38] DRUG SERUM LEVELS OF TNF ANTAGONISTS DO NOT CORRELATE WITH SUBCLINICAL SYNOVITIS BY ULTRASOUND IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS IN CLINICAL REMISSION OR LOW DISEASE ACTIVITY
    Inciarte-Mundo, J.
    Ramirez Garcia, J.
    Estrada Alarcon, P.
    Garcia Manrique, M.
    Gonzalez Navarro, A.
    Saura, C.
    Narvaez, J.
    Rodriguez-Moreno, J.
    Gomez-Centeno, A.
    Yaguee, J.
    Canete, J.
    Sanmarti, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 934 - 935
  • [39] Mortality from cardiovascular causes is reduced in rheumatoid arthritis patients treated with TNF antagonists.
    Gomez-Reino, J.
    Perez-Pampin, Eva
    Descalzo, Miguel A.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S245 - S245
  • [40] Impact of Baseline Disease Activity, Disease Duration and Enrolment Year on CDAI and Boolean Remission in Patients with Rheumatoid Arthritis Treated with Anti-TNF-α Therapy: An Analysis from a Prospective, Observational Registry
    Haraoui, Boulos
    Starr, Michael
    Bessette, Louis
    Baer, Philip
    Arendse, Regan
    Fortin, Isabelle
    Sholter, Dalton
    Psaradellis, Eliofotisti
    Karellis, Angeliki
    Osborne, Brendan
    Nantel, Francois
    Maslova, Karina
    Lehman, Allen
    Tkaczyk, Cathy
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (06) : 1222 - 1222
12345